Chevron this morning gave up on its pursuit of Anadarko Petroleum, which now will go to (much) higher bidder Occidental Petroleum.
😬 Oops: Directors of both Slack and Uber recently made "unauthorized" comments about their respective companies, during CNBC interviews:
• Speaking of the Uber IPO: All indications are that the company will price within its range tonight and begin trading tomorrow on the NYSE.
Company enthusiasts say this is Uber playing for the pop, while critics argue that investor interest was softer-than-expected. A third explanation is what we discussed yesterday, in terms of macro uncertainty over Trump's tariff threat.
• New fund alert: Klamath Technology Credit Partners has launched to make debt investments of between $50 million and $300 million into growth-stage private companies.
Edgewell (NYSE: EPC), maker of Schick razors, agreed to buy shaving products company Harry's for $1.3 billion in cash and stock (79%/21% split).
🚑 Health IQ, a Mountain View, Calif.-based life insurance startup, raised $55 million in Series D funding. Greenspring Associates, Aquiline Technology Growth and Hanwha Asset Management were joined by return backers like Andreessen Horowitz. http://axios.link/8oQn
• ArchiveSocial, a Durham, N.C.-based provider of social media archiving software for government agencies, raised $53 million led by Level Equity. http://axios.link/jbvJ
🚑 Provepharm Life Solutions, a French pharma startup that “revitalizes known molecules,” raised €42.5 million from Société Générale, BNP Paribas, Banque Populaire Méditerranée and Crédit Agricole Alpes Provence. http://axios.link/CCn1
• Heetch, a ride-hail startup focused on France and French-speaking Africa, raised $38 million in Series B funding at around a $150 million valuation. Cathay Innovation and Total Ventures co-led, and were joined by return backers Idinvest Partners, Innov’Allianz, Alven, Felix Capital and Via-ID. http://axios.link/YcgI
🚑 Neural Analytics, a Los Angeles-based developer of a robotic neurovascular ultrasound device, raised $22 million in Series C funding led by Alpha Edison. http://axios.link/mAfF
• ChowNow, a Los Angeles-based online ordering and marketing platform for restaurants, raised $21 million in Series C funding co-led by 3L Capital and return backer Catalyst Investors. http://axios.link/DSm6
• Evident ID, an Atlanta-based provider of identity and credential verification, raised $20 million in Series B funding. Aspect Ventures led, and was joined by Blue Cloud Ventures and return backer NEA. www.evidentid.com
🚑 Pearl, a dental industry-focused spinout from Los Angeles adtech company GumGum, raised $11 million from firms like Craft Ventures. http://axios.link/H8lC
🚑 Velano Vascular, a San Francisco-based developer of vascular access technology products, raised $10 million from Intermountain Healthcare and angels like Marc Benioff and Edward Ludwig. http://axios.link/YTQa
🚑 Astarte Medical, a Yardley, Penn.-based provider of predictive analytics for premature infant care, raised $5 million in Series A funding from Viking Global Investors, Lunsford Capital, OCA Ventures, Keiretsu Forum MidAtlantic, Keiretsu Capital Fund, Ben Franklin Technology Partners, Wing VC and Next Act Fund. www.astartemedical.com
• Stratio, a Portuguese AI startup focused on vehicle preventative maintenance, raised $3 million led by Crane Venture Partners. www.stratioautomotive.com
• Chipper Cash, a no-fee cross-border startup focused on Africa, raised $2.4 million. Deciens Capital led, and was joined by 500 Startups and Liquid 2 Ventures. http://axios.link/N3Nz
• Apax Partners agreed to buy Baltic Classifieds Group, a portfolio of online classified advertising platforms in the Baltics, from Media Investments & Holding. www.diginet.lt
• First Reserve acquired a majority stake in IRISNDT, a Canadian provider of nondestructive testing and materials engineering services. www.irisndt.com
🚑 GenDx, a Dutch provider of molecular diagnostic kits for transplantation, raised growth equity from Ampersand Capital Partners. http://axios.link/QAkN
• Huntington Solutions, a Greer, S.C.-based portfolio company of Mill Point Capital, acquired Radva Corp., a Radford, Va.-based maker of foam packaging for the medical and food markets. www.radva.com
🚑 Axcella Health, a Cambridge, Mass.-based developer of therapies and dietary products for amino acid dysregulation, raised $71 million in its IPO. The pre-revenue company priced 3.6 million shares at $20 (low end of range), and will list on the Nasdaq (AXLA) with Goldman Sachs as lead underwriter. It had raised around $116 million in VC funding from firms like Flagship Pioneering (42.5% pre-IPO stake), Fidelity (13.1%), Nestle Health Sciences (10.4%) and Gurnet Point Capital (6.7%). www.axcellahealth.com
🚑 Cortexyme, a South San Francisco-based developer of Alzheimer’s disease therapeutics, raised $75 million in its IPO. The company priced 4.4 million shares at $17 (middle of range), and will list on the Nasdaq (CRTX) with BAML as lead underwriter. The pre-revenue company raised around $100 million in VC funding from firms like Pfizer (14.71% pre-IPO stake), the Lamond Family (14.37%), Takeda Ventures (12.32%), Sequoia Capital, Vulcan Capital, Verily Life Sciences, EPIQ Capital Group, RSL Investments, Huizenga Capital, Breakout Ventures and Dolby Family Ventures. www.cortexyme.com
• HeadHunter Group, a Russian online job recruitment platform, raised $220 million in its IPO. The company priced 16.3 million shares at $13.50 (high end of range), and will trade on the Nasdaq (HHR) with Morgan Stanley as lead underwriter.
• Mayville Engineering, a Mayville, Wis.-based provider of manufacturing services for OEMs, raised $106 million in its IPO. The company priced 6.3 million shares at $17 (below $19-$21 range). The employee-owned company will trade on the NYSE (MEC) with Baird as lead underwriter, and reports $28 million of net income on $524 million in revenue for 2018. www.mecinc.com
🚑 Milestone Pharmaceuticals, a Montreal-based drug developer focused on cardiovascular disease, raised $83 million in its IPO. The pre-revenue company priced 5.5 million shares at $15 (upsized share count, middle of range, and will trade on the Nasdaq (MIST) with Jefferies as lead underwriter. It had raised US$165 million from RTW Investments (15.7% pre-IPO stake), Fonds de solidarité FTQ (10.1%), BDC Capital (12.1%), Venrock (10%), Domain Associates (9.4%), Pappas Capital (7.3%) and Forbion (6.5%). www.milestonepharma.com
🚑 NextCure, a Beltsville, Md.-based immunotherapy company, raised $75 million in its IPO. The company priced 5 million shares at $15 (middle of range) and will trade on the Nasdaq (NXTC) with Morgan Stanley as lead underwriter. It had raised $160 million from Hillhouse Capital Management, Quan Capital, Eli Lilly, Bay City Capital, Surveyor Capital, Ping An Ventures, Taiho Ventures, ArrowMark Partners, NS Investment and return backers Canaan Partners, OrbiMed Advisors, Pfizer, Sofinnova Ventures and Alexandria Venture Investments. www.nextcure.com
🚑 Clearview Capital agreed to sell AMPS, a Port Orange, Fla.-based healthcare staffing firm, to AMN Healthcare Services (NYSE: AMN) for upwards of $220 million ($200m upfront). www.gowithadvanced.com
🚑 Pfizer (NYSE: PFE) agreed to buy Therachon, a Swiss biotech focused on rare diseases like achondroplasia and short bowel syndrome, for upwards of $810 million ($340m upfront). Therachon had raised around $100 million from Pfizer Ventures, OrbiMed, Versant Ventures, Bpifrance, Tekla Capital, Cowen Group and Novo Holdings. http://axios.link/vSYN
• Carrefour (Paris: CA) is considering options for its Chinese business, including a possible sale that could net around $1 billion, per Bloomberg. http://axios.link/NE2m
• DP World agreed to buy Canadian marine terminal Fraser Surrey Docks from Macquarie Group for just under $300 million. http://axios.link/W0kp
🚑 Novartis (Swiss: NOVN) agreed to buy dry-eye drug Xiidra from Takeda Pharmaceutical (Tokyo: 4502) for upwards of $5.3 billion. http://axios.link/Iekc
• SoftBank Group will invest $4 billion to increase its stake in Yahoo Japan from 12% to 45%. http://axios.link/Rn0J
• 1confirmation, a VC fund focused on early-stage crypto projects, has raised $50 million for its second fund, Axios' Kia Kokalitcheva reports. Founded by ex-Coinbase employee Nick Tomaino, 1confirmation’s first fund was backed by Mark Cuban, Marc Andreessen and Thiel Capital, among others. Tomaino declined to comment.
• 2048 Ventures, co-founded by Alex Iskold (ex-Techstars NYC) and Paul Sethi (ex-CEO of Redbooks), raised $27 million for its debut fund. http://axios.link/B0aA
• Commonfund Capital raised $450 million for its second private equity secondaries fund. www.commonfund.org
• Fuel Capital, a seed-stage firm co-led by Chris Howard and TaskRabbit founder Leah Busque, raised $75 million for its third fund. http://axios.link/o5SZ
• Tom Harrison (ex- Omnicom Group) and Pamela Galassini (ex-Medco Health Solutions) joined cannabis-focused private equity firm Merida Capital Partners as senior operating partners. www.meridacap.com
• Steven List joined Crestline Investors as a managing director focused on the firm’s corporate restructuring funds. He previously was a partner with CR3 Partners. www.crestlineinvestors.com
• Laure Perréard left Edenred to join France’s Tikehau Capital as CFO. www.tikehaucapital.com